Point72 Asset Management, L.P.
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,181,016
+$9,181,016 QoQ
Shares Held
510,908
Ownership
0.484%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 323 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Mar 31, 2026CallValue
$674,560
CallShares
31,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. SRPT ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,181,016 | 510,908 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $674,560 | 31,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $4,465,679 | 207,513 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,794,150 | 145,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $4,603,603 | 238,900 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $855,000 | 50,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $1,496,250 | 87,500 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $1,914,600 | 30,000 | Put | Defined | 2025-07-21 | |
| 2025-03-31 | $1,914,600 | 30,000 | Call | Defined | 2025-07-21 | |
| 2024-09-30 | $4,602,820 | 36,855 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,728,254 | 48,913 | Shares | Defined | 2024-09-16 | |
| 2023-09-30 | $37,256,118 | 307,343 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $2,424,400 | 20,000 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $4,000,260 | 33,000 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $37,719,337 | 329,369 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $3,435,600 | 30,000 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $6,678,690 | 48,456 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $91,192,572 | 703,755 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $94,169,026 | 851,900 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,896,004 | 425,507 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $113,056,123 | 1,447,211 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $103,666,370 | 1,151,209 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $1,485,825 | 16,500 | Call | Defined | 2022-02-14 | |
| 2021-09-30 | $170,718,080 | 1,846,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $32,541,964 | 418,600 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,358,626 | 138,986 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||